Artificial Intelligence-based Decision Support Systems for Precision and Digital Health
0
Sign in to get full access
Overview
- This paper discusses the use of artificial intelligence (AI)-based decision support systems in precision and digital health.
- It covers the key components of these systems, including the reinforcement learning framework, interpretability, and human-AI interaction.
- The paper highlights the potential of these systems to enhance clinical decision-making and patient outcomes.
Plain English Explanation
AI-based decision support systems are tools that use advanced algorithms and machine learning to assist healthcare providers in making better decisions. These systems can analyze vast amounts of data and provide personalized recommendations for patient care, treatment plans, and disease management.
The reinforcement learning framework is a key component of these systems. It allows the AI to learn from interactions with the environment, similar to how humans learn. The AI can explore different actions, observe the outcomes, and adjust its behavior to optimize for the desired goals, such as improving patient health.
Interpretability is also crucial. Healthcare providers need to understand how the AI system arrives at its recommendations, so they can trust the advice and make informed decisions. Techniques like explainable AI can help make the decision-making process more transparent.
Additionally, the interaction between healthcare providers and the AI system is important. The systems need to be designed in a way that enhances trust and collaboration, allowing clinicians to leverage the AI's capabilities while maintaining their own expertise and decision-making authority.
Overall, these AI-based decision support systems have the potential to revolutionize healthcare by providing personalized, data-driven insights that can improve patient outcomes and clinical workflows. However, careful consideration of ethical and privacy concerns is necessary to ensure these systems are developed and deployed responsibly.
Technical Explanation
The paper presents a comprehensive overview of the key components and considerations in the development of AI-based decision support systems for precision and digital health.
The Reinforcement Learning Framework: The authors explain how reinforcement learning can be leveraged in these systems. Reinforcement learning allows the AI to learn by interacting with the environment, exploring different actions, and receiving rewards or penalties based on the outcomes. This enables the system to continuously optimize its decision-making process to achieve the desired goals, such as improving patient health and treatment outcomes.
Interpretability: The paper emphasizes the importance of interpretability in these AI-based systems. Healthcare providers need to understand how the AI arrives at its recommendations to trust and effectively leverage the system's capabilities. The authors discuss techniques like explainable AI, which aims to make the decision-making process more transparent and understandable.
Human-AI Interaction: The paper also explores the critical role of the interaction between healthcare providers and the AI system. It highlights the need to design these systems in a way that enhances trust, collaboration, and the integration of human expertise with the AI's capabilities. This can help ensure that the AI's recommendations are appropriately contextualized and integrated into the clinical decision-making process.
The authors also discuss the potential of these AI-based decision support systems to transform healthcare by providing personalized, data-driven insights that can improve patient outcomes and clinical workflows. However, they note the importance of addressing ethical and privacy concerns to ensure the responsible development and deployment of these technologies.
Critical Analysis
The paper provides a thorough and well-researched overview of the key aspects of AI-based decision support systems for precision and digital health. The authors' emphasis on interpretability, human-AI interaction, and the responsible development of these technologies is particularly commendable.
One potential area for further research could be the exploration of specific use cases and case studies that demonstrate the real-world impact of these AI-based systems. While the paper discusses the potential benefits, providing more concrete examples of successful implementations and their tangible outcomes could further strengthen the case for the adoption of these technologies.
Additionally, the paper could delve deeper into the challenges and limitations of these systems, such as the potential for algorithmic bias, the need for robust data governance and security measures, and the potential for these technologies to exacerbate health disparities if not deployed equitably. Addressing these concerns would help provide a more well-rounded critical analysis of the field.
Overall, the paper provides a solid foundation for understanding the key aspects of AI-based decision support systems and their importance in the realm of precision and digital health. The authors' focus on interpretability, human-AI interaction, and responsible development is a valuable contribution to the ongoing discussions in this rapidly evolving field.
Conclusion
This paper presents a comprehensive overview of the use of AI-based decision support systems in precision and digital health. It highlights the key components of these systems, including the reinforcement learning framework, interpretability, and the crucial interaction between healthcare providers and the AI.
The authors emphasize the potential of these systems to transform healthcare by providing personalized, data-driven insights that can improve patient outcomes and clinical workflows. However, they also stress the importance of addressing ethical and privacy concerns to ensure the responsible development and deployment of these technologies.
By exploring the technical aspects of these AI-based decision support systems and the critical considerations surrounding their implementation, this paper contributes to the ongoing dialogue on the role of advanced technologies in the healthcare industry. As the field of precision and digital health continues to evolve, the insights provided in this paper will be valuable for researchers, healthcare providers, and policymakers alike.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
Artificial Intelligence-based Decision Support Systems for Precision and Digital Health
Nina Deliu, Bibhas Chakraborty
Precision health, increasingly supported by digital technologies, is a domain of research that broadens the paradigm of precision medicine, advancing everyday healthcare. This vision goes hand in hand with the groundbreaking advent of artificial intelligence (AI), which is reshaping the way we diagnose, treat, and monitor both clinical subjects and the general population. AI tools powered by machine learning have shown considerable improvements in a variety of healthcare domains. In particular, reinforcement learning (RL) holds great promise for sequential and dynamic problems such as dynamic treatment regimes and just-in-time adaptive interventions in digital health. In this work, we discuss the opportunity offered by AI, more specifically RL, to current trends in healthcare, providing a methodological survey of RL methods in the context of precision and digital health. Focusing on the area of adaptive interventions, we expand the methodological survey with illustrative case studies that used RL in real practice. This invited article has undergone anonymous review and is intended as a book chapter for the volume Frontiers of Statistics and Data Science edited by Subhashis Ghoshal and Anindya Roy for the International Indian Statistical Association Series on Statistics and Data Science, published by Springer. It covers the material from a short course titled Artificial Intelligence in Precision and Digital Health taught by the author Bibhas Chakraborty at the IISA 2022 Conference, December 26-30 2022, at the Indian Institute of Science, Bengaluru.
Read more7/24/2024
🏅
0
Reinforcement Learning in Modern Biostatistics: Constructing Optimal Adaptive Interventions
Nina Deliu, Joseph Jay Williams, Bibhas Chakraborty
In recent years, reinforcement learning (RL) has acquired a prominent position in health-related sequential decision-making problems, gaining traction as a valuable tool for delivering adaptive interventions (AIs). However, in part due to a poor synergy between the methodological and the applied communities, its real-life application is still limited and its potential is still to be realized. To address this gap, our work provides the first unified technical survey on RL methods, complemented with case studies, for constructing various types of AIs in healthcare. In particular, using the common methodological umbrella of RL, we bridge two seemingly different AI domains, dynamic treatment regimes and just-in-time adaptive interventions in mobile health, highlighting similarities and differences between them and discussing the implications of using RL. Open problems and considerations for future research directions are outlined. Finally, we leverage our experience in designing case studies in both areas to showcase the significant collaborative opportunities between statistical, RL, and healthcare researchers in advancing AIs.
Read more5/14/2024
🏷️
0
Designing Interpretable ML System to Enhance Trust in Healthcare: A Systematic Review to Proposed Responsible Clinician-AI-Collaboration Framework
Elham Nasarian, Roohallah Alizadehsani, U. Rajendra Acharya, Kwok-Leung Tsui
This paper explores the significant impact of AI-based medical devices, including wearables, telemedicine, large language models, and digital twins, on clinical decision support systems. It emphasizes the importance of producing outcomes that are not only accurate but also interpretable and understandable to clinicians, addressing the risk that lack of interpretability poses in terms of mistrust and reluctance to adopt these technologies in healthcare. The paper reviews interpretable AI processes, methods, applications, and the challenges of implementation in healthcare, focusing on quality control to facilitate responsible communication between AI systems and clinicians. It breaks down the interpretability process into data pre-processing, model selection, and post-processing, aiming to foster a comprehensive understanding of the crucial role of a robust interpretability approach in healthcare and to guide future research in this area. with insights for creating responsible clinician-AI tools for healthcare, as well as to offer a deeper understanding of the challenges they might face. Our research questions, eligibility criteria and primary goals were identified using Preferred Reporting Items for Systematic reviews and Meta-Analyses guideline and PICO method; PubMed, Scopus and Web of Science databases were systematically searched using sensitive and specific search strings. In the end, 52 publications were selected for data extraction which included 8 existing reviews and 44 related experimental studies. The paper offers general concepts of interpretable AI in healthcare and discuss three-levels interpretability process. Additionally, it provides a comprehensive discussion of evaluating robust interpretability AI in healthcare. Moreover, this survey introduces a step-by-step roadmap for implementing responsible AI in healthcare.
Read more4/11/2024
👀
0
Evaluating Physician-AI Interaction for Cancer Management: Paving the Path towards Precision Oncology
Zeshan Hussain, Barbara D. Lam, Fernando A. Acosta-Perez, Irbaz Bin Riaz, Maia Jacobs, Andrew J. Yee, David Sontag
We evaluated how clinicians approach clinical decision-making when given findings from both randomized controlled trials (RCTs) and machine learning (ML) models. To do so, we designed a clinical decision support system (CDSS) that displays survival curves and adverse event information from a synthetic RCT and ML model for 12 patients with multiple myeloma. We conducted an interventional study in a simulated setting to evaluate how clinicians synthesized the available data to make treatment decisions. Participants were invited to participate in a follow-up interview to discuss their choices in an open-ended format. When ML model results were concordant with RCT results, physicians had increased confidence in treatment choice compared to when they were given RCT results alone. When ML model results were discordant with RCT results, the majority of physicians followed the ML model recommendation in their treatment selection. Perceived reliability of the ML model was consistently higher after physicians were provided with data on how it was trained and validated. Follow-up interviews revealed four major themes: (1) variability in what variables participants used for decision-making, (2) perceived advantages to an ML model over RCT data, (3) uncertainty around decision-making when the ML model quality was poor, and (4) perception that this type of study is an important thought exercise for clinicians. Overall, ML-based CDSSs have the potential to change treatment decisions in cancer management. However, meticulous development and validation of these systems as well as clinician training are required before deployment.
Read more4/24/2024